Kesimpta (ofatumumab)
Patient Assistance Program Guide — Novartis Patient Assistance Foundation (NPAF)
Do You Qualify?
Income
Up to $75,300 for a single person
Insurance
Uninsured or underinsured; Medicare Part D patients may be eligible if they meet financial criteria and meet specific coverage requirements.
Residency
U.S. resident, Puerto Rico, or U.S. Virgin Islands with a valid address
Income Limits (500% FPL)
Calculated based on 500% of the 2025 FPL for specialty medications.
Based on 2025 HHS Federal Poverty Level guidelines.
# Novartis Patient Assistance Foundation (NPAF): Your Guide to Getting Kesimpta at No Cost
Who Qualifies for the Novartis Patient Assistance Foundation (NPAF)?
If you have been prescribed Kesimpta (ofatumumab) and cannot afford it, you may qualify for free medication through the Novartis Patient Assistance Foundation (NPAF). This program provides Kesimpta at no cost to eligible patients. To qualify, you generally need to meet income limits — for a single-person household, your annual income must be at or below $75,300. You must also be uninsured or underinsured, meaning your current insurance does not adequately cover the cost of Kesimpta. Some Medicare Part D patients may also be eligible if they meet both the income requirements and specific coverage criteria. If you think you may qualify, this guide walks you through every step.
---
About Kesimpta (ofatumumab)
Kesimpta is a prescription medication approved by the FDA to treat relapsing forms of multiple sclerosis (RMS). This includes clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS. Kesimpta belongs to a class of drugs called CD20-directed cytolytic antibodies. It is administered by self-injection. As a specialty biologic medication, Kesimpta carries a high list price that can make it unaffordable without insurance or financial assistance. The NPAF program exists to help patients who lack adequate coverage access this medication without bearing that cost on their own.
---
Income Eligibility: Full Breakdown
NPAF uses your household size and annual income to determine eligibility. The income limits below are based on 500% of the 2025 Federal Poverty Level (FPL) for specialty medications:
| Household Size | Maximum Annual Income |
|---|---|
| 1 person | $75,300 |
| 2 persons | $102,200 |
| 3 persons | $129,100 |
| 4 persons | $156,000 |
If your household has more than four people, the income limit increases with each additional member. You should still apply and ask about your specific situation.
Income is typically verified using your most recent federal tax return, a W-2 form, or three months of recent pay stubs. If your income has changed significantly since last year — for example, due to job loss — pay stubs may better reflect your current situation and could work in your favor.
If your income is above these limits, you may not qualify for the NPAF free drug program. However, you still have options. The next sections and the alternatives section below outline other ways to reduce your cost.
---
Insurance Requirements Explained
Your insurance status plays a major role in whether you qualify. Here is a simple breakdown:
---
Step-by-Step: How to Apply
Step 1: Gather your documents.
Before you start, collect the following: a completed NPAF application form with your prescriber's signature, proof of income (most recent tax return, W-2, or three months of pay stubs), and a valid prescription for Kesimpta.
Step 2: Choose your application method.
You have several options:
Step 3: Have your prescriber sign the application.
Your doctor or their office staff must sign the application form. Many offices handle this routinely, so do not hesitate to ask.
Step 4: Submit everything together.
Incomplete applications take longer to process. Make sure all documents are included before submitting.
Step 5: Wait for a decision.
NPAF typically processes applications within 2 to 3 business days. You or your prescriber's office will be notified of the outcome.
Step 6: Receive your medication.
If approved, Kesimpta is shipped directly to your home. You do not need to pick it up at a pharmacy.
---
What to Expect: Timeline and Delivery
After submitting a complete application, most patients receive a decision within 2 to 3 business days. NPAF will notify you — and typically your prescriber's office — once a decision has been made. If approved, Kesimpta will be shipped directly to your home address, so no pharmacy pickup is required.
Approval through NPAF is not permanent. You will need to reauthorize your enrollment once per year to continue receiving the medication at no cost. Watch for renewal notices and begin gathering updated income documents before your annual deadline to avoid a gap in your supply.
---
Alternatives If You Don't Qualify
If you do not meet NPAF's eligibility requirements, you still have options worth exploring:
Biosimilars: There are currently no FDA-approved biosimilar alternatives to Kesimpta (ofatumumab). This may change in the future, so it is worth checking periodically.
Manufacturer savings card (insured patients): If you have commercial insurance, Novartis offers a co-pay support program for Kesimpta. Eligible patients with private insurance may be able to reduce their out-of-pocket costs significantly. Visit https://www.kesimpta.com/co-pay-support to learn more and enroll.
State Pharmaceutical Assistance Programs (SPAPs): Many states run their own drug assistance programs, especially for Medicare beneficiaries. Search for your state's SPAP through your state health department or Medicare's official website.
NeedyMeds.org: This free, nonprofit database lists hundreds of patient assistance programs, co-pay programs, and disease-specific funds. It is a useful tool if you are looking for additional resources beyond the NPAF program.
---
*This guide is for informational purposes only and does not constitute medical or legal advice. Eligibility determinations are made solely by Novartis. Program terms may change — verify current requirements at [https://www.kesimpta.com/support/financial-support](https://www.kesimpta.com/support/financial-support) before applying.*
---
Documents You'll Need
If You Don't Qualify for the Assistance Program
Manufacturer Savings Card (for insured patients)
Novartis offers a savings card that may reduce your out-of-pocket cost if you have commercial insurance. Ask your prescriber or pharmacist for current savings card details.
Common Questions
NPAF typically processes completed applications within 2 to 3 business days. Make sure your application includes all required documents — the application form with your prescriber's signature, proof of income, and a valid prescription — to avoid delays.
Yes. Your prescriber must sign the application form for it to be considered complete. Most doctor's offices are familiar with patient assistance program paperwork and can help you get this done quickly.
If you are approved through the NPAF program, Kesimpta is shipped directly to your home. You do not need to visit a pharmacy or specialty distributor to receive your medication.
Possibly. Medicare Part D patients are not automatically excluded from the NPAF program. Eligibility depends on meeting the income limits and specific coverage requirements. Call NPAF directly at (800) 277-2254 to discuss your Medicare situation before applying.
You will need to reauthorize your enrollment once a year to keep receiving Kesimpta through the program. You will typically need to submit updated income documentation. Plan ahead so there is no gap in your medication supply.
Ready to Apply for Kesimpta Assistance?
RX Advantages handles the entire Novartis Patient Assistance Foundation (NPAF) application on your behalf — paperwork, physician coordination, and refill tracking. It takes about 15 minutes to get started.
No SSN required on the web form · From $49.95/month